- Price
- $539.72
- Day
- -0.16%
- Mkt Cap
- $7.05B
- 52W Range
- $365.21 – $551.68
- Volume
- 149.9K
- Beta
- 0.51
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
Chemed Corporation (CHE) Q2 2026 Earnings Call Transcript
Read full article
Chemed NYSE: CHE reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face higher customer-acquisition costs.
Read full article
Arrowstreet Capital Limited Partnership cut its position in shares of Chemed Corporation (NYSE: CHE) by 1.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 152,469 shares of the company's stock after selling 2,050 shares during the period. Arrowstreet Capital
Read full article
CINCINNATI, July 28, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2026, versus the comparable prior-year period. Results for Quarter Ended June 30, 2026 Consolidated operating results: Revenue increased 8.8% to $673.3 million GAAP Diluted Earnings-per-Share (EPS) of $5.13, an increase of 43.7% Adjusted Diluted EPS of $6.06, an increase of 41.9% VITAS segment operating results: Net Patient Revenue of $443.3 million, an increase of 11.9% Average Daily Census (ADC) of 23,687, an increase of 6.1% Admissions of 19,125, an increase of 9.0% Net Income, excluding certain discrete items, of $61.3 million, an increase of 60.5% Adjusted EBITDA, excluding Medicare Cap, of $80.6 million, an increase of 20.6% Adjusted EBITDA margin, excluding Medicare Cap, of 18.2%, an increase of 196-basis points Roto-Rooter segment operating results: Revenue of $229.9 million, an increase of 3.3% Net Income, excluding certain discrete items, of $33.8 million, essentially flat Adjusted EBITDA of $48.5 million, essentially flat Adjusted EBITDA margin of 21.1%, a decline of 77-basis points VITAS VITAS net revenue was $443.3 million in the second quarter of 2026, which is an increase of 11.9% when compared to the prior-year period.
Read full article
Chemed (CHE) came out with quarterly earnings of $6.06 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $4.27 per share a year ago.
Read full article
Gabelli Funds LLC lessened its stake in Chemed Corporation (NYSE: CHE) by 8.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,138 shares of the company's stock after selling 2,813 shares during the quarter. Gabelli Funds LLC owned
Read full article
Entropy Technologies LP grew its holdings in shares of Chemed Corporation (NYSE: CHE) by 491.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,195 shares of the company's stock after buying an additional 5,979 shares during the quarter. Entropy
Read full article